Given Rises to 5-Month High as Patients Enroll in Pillcam Trial
By Shoshanna Solomon -
2012-01-04T13:52:49Z
Given Imaging Ltd. (GIVN) advanced to the highest in more than five months after the maker of a pill-sized camera to diagnose digestive ailments said about 700 patients have enrolled in a PillCam COLON 2 trial.
The shares gained (GIVN) 2.2 percent to 69.21 shekels, the highest intraday level since July 27, at 3:48 p.m. in Tel Aviv.
To contact the reporter on this story: Shoshanna Solomon in Tel Aviv at ssolomon22@bloomberg.net
To contact the editor responsible for this story: Claudia Maedler at cmaedler@bloomberg.net
Sponsored Link
Rate this Page
Bloomberg moderates all comments. Comments that are abusive or off-topic will not be posted to the site. Excessively long comments may be moderated as well. Bloomberg cannot facilitate requests to remove comments or explain individual moderation decisions.